By Anescribe
Report updated May 12, 2026
Anescribe
For anesthesiologists requiring mobile-first, HIPAA-compliant tools for pre-operative assessment and intra-operative charting.
Anescribe is an established medical app that is completely free. With a 5.0/5 rating from 1 reviews, it shows polarized user reception.
What is Anescribe?
Anescribe is a medical documentation app for anesthesiologists that captures patient vitals and pre-operative data via OCR and voice transcription on iPad.
Anesthesiologists hire this tool to reduce manual charting time during pre-operative assessments, allowing for faster patient throughput without sacrificing documentation accuracy.
Current Momentum
v1.1 · 1mo ago
Maintenance- Launched initial iPad charting utility.
Active Nemesis
Fragmented niche
No dominant direct rival identified yet — see Other Rivals below.
Other Rivals
Rating Pulse 🇺🇸
What makes this app unique?
What Does It Look Like?
How Is The App's Momentum Right Now?
Loading...
What Are The Key Features?
Photograph medicine bottles for instant data extraction via optical character recognition
Record vital signs and notes without internet connectivity, syncing automatically upon reconnection
Medically fluent speech-to-text for hands-free note-taking during procedures
How much does it cost?
- Free app with no subscription or IAP listed
The app currently operates as a free utility with no visible monetization, likely serving as a lead-in for the broader Anescribe suite.
Who Built It?
What other apps does Anescribe make?
Spanislate: Medical Spanish
Medical
Elescan
Medical
Careslate: Medical Translator
Medical
Innaslide
Utilities
What do users think recently?
Analysis in progress, available soon
What is the competitive landscape for Anescribe?
How's The Medical Market?
Market outlook for this category
Available very soon
The rivals identified
Peers
Deep EHR integration provides institutional-level data connectivity that Anescribe currently lacks for enterprise clinical workflows.
Established market presence and long-term deployment history create significant switching costs for large-scale healthcare facilities.
The outtake for Anescribe
Strengths to defend, gaps to attack
Core Strengths
- Offline charting capability ensures documentation continuity during network outages in clinical environments.
- Voice transcription provides hands-free data entry, reducing the physical documentation burden for anesthesiologists.
Critical Frictions
- Zero monetization strategy limits long-term development resources.
- No cloud-sync or EHR integration prevents institutional adoption.
Growth Levers
- Developing B2B partnerships with hospital systems could provide a distribution channel for enterprise-grade charting tools.
Market Threats
- Established EHR providers can integrate similar OCR and voice features into existing workflows, rendering standalone utilities redundant.
What are the next best moves?
Audit EHR integration requirements because lack of connectivity limits institutional adoption → unlock enterprise market segment.
Competitor analysis shows PointClickCare wins on institutional data connectivity, a feature currently missing in Anescribe.
Trade-off: Pause development of additional OCR medicine categories — EHR connectivity is the primary barrier to institutional revenue.
A counter-intuitive read
The lack of monetization is not a weakness but a deliberate strategy to build a user base of individual anesthesiologists before locking them into a future enterprise platform.
Feature Gaps vs Competitors
- Deep EHR integration (available in PointClickCare Point of Care but absent here)
Key Takeaways
Anescribe provides high-utility documentation for individual providers, but its lack of EHR integration and monetization prevents long-term viability, so the PM should prioritize institutional connectivity to transition from a free utility to a sustainable B2B product.
Where Is It Heading?
Stable
The clinical documentation market is consolidating around EHR-integrated solutions that automate data flow across hospital departments. Anescribe remains exposed as a standalone tool, so long-term success requires shifting from a consumer-utility model to an enterprise-integrated platform.
The app remains a standalone utility, which limits its growth to individual practitioners rather than institutional hospital deployments.